Funded Research

Role of yo T cells and HMG-1 in staphylococcal toxic shock syndrome

Year

2004

Host institution

University of British Columbia

Research location

Vancouver Hospital & Health Sciences Centre

Partner

Supervisor

CO-lEad

Superantigens are secreted toxins from some kinds of bacteria that stimulate a massive and damaging immune response in the body, causing a number of diseases. For example, TSST-1 is a superantigen that can cause toxic shock syndrome which may lead to multiple organ failure and often death. Shirin Kalyan is studying how the immune system responds to superantigens at the cellular level. Superantigens activate between 5 to 30 percent of all T cells (white blood cells involved in fighting infection). This ability to stimulate such a large pool of immune cells leads to a massive inflammatory response. In contrast, conventional antigens activate less than .01 per cent of T cells. Shirin is investigating whether a particular type of primodial innate T cell can influence the immune response that causes toxic shock syndrome. The findings could lead to more effective treatments for toxic shock syndrome and other immune disorders caused by superantigens.

Building research careers

Since 2001, we’ve supported over 3,000 BC health researchers to launch programs, drive innovations, and attract millions in new research investment.

View all funded research

Funded research